Past Conference Speakers
John Reed, M.D., Ph.D.EVP, Pharmaceuticals, Research & DevelopmentJohnson & Johnson Innovative Medicine
Mike VarneyFormer Exectutive VP, Genentech Research & Early Development, Genentech
Mira Chaurushiya, Ph.D.Managing DirectorWestlake Village BioPartners
Ben Cravatt, Ph.D.Professor & Gilula Chair, Chemical BiologyThe Scripps Research Institute
Marianne DeCEO, Vir Biotechnology
Steve BartzVice President Corporate Development, Seattle Genetics
Daniel Estes, Ph.D.General PartnerFrazier Healthcare Partners
Stephen Ferruolo, J.D., Ph.D.ProfessorUSD School of Law
Rusty GagePresident, Salk Institute
Carol GallagherVenture Advisor, New Enterprise Associates, Inc. (NEA)
Kevin GrimesProfessor of Chemical and Systems Biology; Co-director of the SPARK Program at Stanford University School of Medicine
Jeff HatfieldCEO, Vividion
Grace Han McMahonAVP and Head, Pacific BD&LMerck
Katie HewittChief Business Officer, Lilly New Ventures at Eli Lilly and Company
Richard Heyman, Ph.D.Venture PartnerARCH Ventures
John Hood, Ph.D.Founder, CEO & Executive ChairmanEndeavor BioMedicines
Mike JungDistinguished Professor of Chemistry, UCLA
Chau Quang KhuongGeneral Partner and Senior Advisor, Catalio Capital Management
Scott LippmanDistinguished Professor of Medicine, Director of the Moores Cancer Center, Chugai Pharmaceutical Chair, and Associate Vice Chancellor at UC San Diego School of Medicine
Stefan LuziPartner, Gilde Healthcare
Carole NuechterleinHeadRoche Venture Fund
Scott PlatshonPartner, EcoR1 Capital, LLC
Armin RumpDirector of Global Business Development, Otsuka
Camille SamuelsDirectorVenrock Boards
Jay StamatisCEOMBrace Therapeutics
Matt Tremblay, Ph.D.Chief Executive OfficerBlackbird Laboratories
Lesley Stolz, Ph.D.Head, JLABS California
Alex Szidon, PhDChief Business Officer, Resilience
Jeffrey Warmke, PhDSenior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
Asish Xavier, Ph.D.Vice President, Venture InvestmentsJohnson & Johnson Innovation – JJDC